Genes to Cells
MAEDA Et Al. determined that hVRK1, a human homologue of dNHK1, phosphorylates nucleosomal H2A T120 around the promoter region of genes such as CCND1 and regulates transcription (Aihara et al., 2016) , as the neighboring histone H2A lysine 119 is a well-known ubiquitylation site that is closely associated with transcriptional repression (Aihara et al., 2016; Wang et al., 2004) . Because the substrate specificity of NHK1 is very tight, it is expected that there is a cross talk between histone H2A lysine 119 ubiquitylation and threonine 120 phosphorylation. According to the accepted model that ubiquitylated H2A inhibits transcriptional initiation by inhibiting di-and trimethylation of H3K4 by MLL, it has been suggested that histone H2A serine 121/threonine 120 phosphorylation activates transcriptional initiation by inhibiting ubiquitylation, which in turn inhibits transcriptional initiation (Aihara et al., 2016) .
However, Bub1 has been identified as a mitotic histone H2A S121 kinase in fission yeast (Kawashima, Yamagishi, Honda, Ishiguro, & Watanabe, 2010) and has been reported to be a multitask protein kinase required for proper chromosome segregation in eukaryotes. It was shown that Bub1 phosphorylates the conserved histone H2A serine 121, which corresponds to H2A threonine 120 in humans. The histone H2A S121A mutant, in which all cellular H2A serine 121 is replaced by alanine, mimics the Bub1 kinase-dead mutant (Bub1-KD) in perturbing the centromeric localization of the Shugoshin protein, which is also associated with the pericentromeric chromosomal region and plays multiple roles in ensuring the accuracy of chromosome segregation during both mitosis and meiosis (Asghar et al., 2015; Baron et al., 2016; Lin, Jia, Tomchick, Luo, & Yu, 2014; Liu, Jia, & Yu, 2013; Liu et al., 2015; Marston, 2015) . In addition to its role in histone H2A phosphorylation, it has also been reported that over-expression of Bub1 drives chromosomal instability through hyperactivation of Aurora B kinase (Ricke, Jeganathan, & van Deursen, 2011) . This enzymatic subunit of the chromosomal passenger complex (CPC) plays a crucial role in error-free chromosome segregation (Hindriksen, Lens, & Hadders, 2017) . The CPC binds directly to phosphorylated histone H3T3, and inhibition of haspin kinase, which is responsible for H3T3 phosphorylation, results in dispersion of the CPC over the chromosome arms (De Antoni, Maffini, Knapp, Musacchio, & Santaguida, 2012) . Thus, the importance of histone H2A or H3 phosphorylation in chromosomal stability still needs to be clarified.
In this study, we showed that human BUB1 phosphorylates nucleosomal H2A T120 assembled by salt dialysis in vitro. In addition, BUB1 knockdown (KD) caused the formation of multinucleated cells and impaired cancer cell growth. At last, the histone H2A T120D and T120E mutations, which mimic phosphorylated threonine, by themselves repressed the phenotype caused by hBUB1 KD. These results strengthen the case for the importance of histone H2A T120 phosphorylation by BUB1 in chromosome segregation during mitosis.
| RESULTS

| rBUB1 phosphorylates human nucleosomal H2A T120 assembled in vitro
We previously determined that dNHK1 phosphorylates nucleosomal histone H2A T119 during embryonic development (Aihara et al., 2004) . We also determined that hVRK1, a human homologue of Drosophila NHK1, also phosphorylates histone H2A T120. Abnormal regulation by hVRK1 in cancer cell lines such as HT1080 and MDA-MB-231 shows hyperphosphorylation of histone H2A T120, resulting in dysregulation of oncogenes, such as Cyclin D1, and cancer development. However, it has been reported that yeast Bub1 phosphorylates histone H2A during M phase and prevents chromosomal instability (Kawashima et al., 2010) . In vitro, it was found that human BUB1 phosphorylates the free fusion protein GST-histone H2A T120 (Kawashima et al., 2010) . We then examined whether recombinant hBUB1 phosphorylates nucleosomal H2A assembled in vitro. We expressed FLAG-tagged hBUB1 in bacteria, and although degradation was observed, full-length hBUB1 was a major expression product (as indicated by the arrowhead in Figure 1a ). We also assembled human nucleosomes using salt dialysis. Phosphorylation of H2A T120 by hBUB1 and dNHK1/VRK1 was observed using western blot analysis (Figure 1b) . Dot blot hybridization also confirmed that human recombinant BUB1 phosphorylates H2A T120 in a nucleosomal array (Figure 1c ).
We previously suggested that an increase in histone H2A T120 phosphorylation in certain cancer cell lines, including HeLa cells, and in normal epithelium in M phase (Aihara et al., 2016 ) is because of the mitotic BUB1 kinase. However, some of the cancer cell lines, such as HT1080 and MB231, show inappropriate hyperphosphorylation, even in interphase. We reported that this hyperphosphorylation of H2A T120 is catalyzed by hVRK1. In addition to this inappropriate bulk hyperphosphorylation, VRK1 phosphorylates nucleosomal H2A T120 around the gene promoter region (Aihara et al., 2016) . In this study, we confirmed that bulk H2A T120 phosphorylation, which is enhanced during M phase in HeLa cells, is catalyzed by hBUB1, as it is reduced by knockdown using either of two siRNA oligonucleotides, siBUB1-1 or siBUB1-2 (Figure 1d ).
| hBUB1 is recruited to centromeric and pericentromeric repeat sequences during M phase
The expression of hBUB1 was examined in two cancer cell lines, HeLa and Du145, in which bulk histone H2A T120 phosphorylation increases during M phase. Corresponding to the increased phosphorylation of H2A T120, hBUB1 levels increased and band mobility decreased, possibly because of the hBUB1 modification (Figure 2a ). hBUB1 localization was examined at the γ-ALR junction, which is near the boundary between the centromeric and pericentromeric regions (Mravinac et al., 2009) , and at the DXZ1 alpha-satellite region. In HeLa cells, hBUB1 was recruited to the X chromosome centromeric and pericentromeric sequences, in which H2A T120 phosphorylation increased during M phase, as shown by ChIP assay (Figure 2b ). These findings confirmed previous observations in fission yeast (Kawashima et al., 2010) . By knocking down hBUB1, cell growth was impaired, suggesting the importance of hBUB1 in cancer cell proliferation (Figure 2c ).
| Knocking down hBUB1 causes missegregation, resulting in the formation of multinucleated cells
To find out what happens to cancer cells when hBUB1 is knocked down, we carried out a TUNEL assay using staurosporine as positive control. The Q2 cell fraction was examined for the occurrence of apoptosis-fragmented DNA labeled with fluorescein-12-dUTP. Staurosporine treatment increased this labeled DNA in the Q2 fraction, but siBUB1 treatment did not (Figure 3a) . We compared the Q2 fraction after staurosporine treatment with the Q2 fraction after siBUB1 treatment, and the latter was significantly lower than the former (n = 2; p < 0.05). We then reanalyzed the Q2 and Q4 fractions of Figure 3a in Figure 3b . We found that the Q4 fraction of Figure 3b , in which BUB1 was knocked down, contained cells with more than 4N DNA content (49.44% compared with the control siRNA Q4 fraction of 8.579%, Figure 3b ). We also analyzed the cells, which correspond to the Q3 fractions of Figure 3b , and found that siBUB1 increased the mitotic cell fraction compared with the untreated or siControl-treated samples ( Figure 3c ). These results suggest that BUB1 KD causes mitotic cell death rather than apoptosis.
We carried out immunofluorescence analysis to determine in detail the effects of BUB1 KD on cancer cells. First, demecolcine was preferred to increase the length of metaphase by interfering with microtubules and thereby synchronize the cells. Next, BUB1 KD increased inappropriate segregation (indicated by asterisks), the formation of multinucleated cells (indicated by an arrowhead), and the formation of large nuclei cells (indicated by an arrow, Figure 4 ). Abnormal features were counted in seven independent experiments, and the results are shown in Figure 5a . To confirm that the decrease in histone H2A T120 phosphorylation caused this phenotype, cells harboring mutant histone H2A T120 aspartate or glutamate (T120D or T120E), which mimic phosphorylation, or the H2A T120 alanine mutant (T120A) as control were examined. BUB1 KD by siBUB1-1 or siBUB1-2 increased abnormal mitosis and the number of multinucleated cells to 34.2% and 33.4%, respectively. Mutant histones H2A T120D and T120E, mimicking phosphothreonine, significantly decreased the numbers of these abnormal cells but not H2A T120A ( Figure 5 ). This result suggests that the loss of histone H2A phosphorylation directly causes inappropriate segregation and formation of multinucleated cells.
F I G U R E 1
Recombinant human BUB1, as well as dNHK1/ dVRK1, phosphorylates nucleosomal H2A in vivo and in vitro. (a) Expression of FLAG-tagged hBUB1 (rhBUB1) kinases in E. coli. hBUB1 (100 ng) was isolated by 13% SDS-PAGE, and degradation is indicated. (b) rhBUB1 (20 ng) was incubated with 50 ng of saltdialyzed chromatin. H2A T120 phosphorylation was detected by western blotting with an anti-pT120 antibody. The loading amount was confirmed by western blotting with anti-H3 antibody, and Coomassie staining of the 13% SDS-PAGE is shown below. (c) rhBUB1 (20 ng) was incubated with 50 ng of salt-dialyzed chromatin, and H2A T120 phosphorylation was detected by dot blotting with an anti-pT120 antibody. The loading amount was confirmed by amido black staining and anti-CHs antibody reprobing of the same membrane. (d) HeLa cells were plated at a density of 10 5 cells per 35-mm dish in DMEM with 10% fetal calf serum and subjected to siBUB1 knockdown using two different oligos, siBUB1-1 or siBUB1-2, treatment with control oligo (siControl) or no treatment (NT). Cell lysates were prepared after 48 hr and subjected to western blotting with an anti-pT120 antibody. The loading amount was confirmed by western blot reprobing with anti-CHs antibody and amido black staining of the same membrane Genes to Cells MAEDA Et Al.
| Knocking down hBUB1 inhibits tumor growth in vivo
To explore the possibility of an anticancer nucleic acid drug, we knocked down BUB1 and examined tumor growth. BUB1 KD significantly inhibited tumor growth in nude mice over a period of 4 weeks ( Figure 6 ).
| DISCUSSION
We previously determined that NHK1 catalyzes H2A T119 (equivalent to T120 in mammals) phosphorylation in Drosophila embryos. This kinase is localized to the mitotic nucleus during the initial 13 cycles of cell division, which lack an interphase (Aihara et al., 2004) . Of late, we showed that the mammalian homologue of dNHK1, known as VRK1, catalyzes H2A T120 phosphorylation around the gene promoter region and activates transcription. We found that histone H2A T120 phosphorylation increases in certain cancer cell lines, including HeLa cells, and in normal epithelium in M phase (Aihara et al., 2016) , possibly because of the mitotic BUB1 kinase. However, some of the cancer cell lines, such as HT1080 and MB231, show inappropriate hyperphosphorylation, even in interphase. We reported that this hyperphosphorylation of H2A T120 is reduced by knocking down hVRK1. In addition to this inappropriate bulk hyperphosphorylation, VRK1 phosphorylates nucleosomal H2A T120 around the gene promoter region in all cell lines tested (Aihara et al., 2016) . VRK1 catalyzed bulk H2A T120 phosphorylation, which is inappropriately increased irrespective of the cell cycle phase in HT1080 and MDA-MB-231 cells but does not affect H2A T120 phosphorylation enhancement during M phase in HeLa cells (Aihara et al., 2016) . In addition, we showed that H2A T120 phosphorylation by VRK1 around the Cyclin D1 promoter region plays a role in carcinogenesis. The H2A T120D mutation behaved like T120 phosphorylation and transformed NIH3T3 cells. Thus, we suggest that inappropriate bulk H2A F I G U R E 4 BUB1 knockdown generates abnormal nuclei. Circular coverslips were placed into a 24-well plate, and HeLa cells were plated at a density of 1.25 × 10 4 per well. Forty-eight hours after siControl, siBUB1-1, or siBUB1-2 treatment or 20 hr after demecolcine treatment, the cells were fixed, and immunofluorescence chemistry was carried out using anti-BUB1 and anti-α-tubulin antibodies. DNA was stained using Hoechst 33342 dye, and demecolcine (32 nM) was used for metaphase synchronization T120 hyperphosphorylation affects the transcription of oncogenes such as Cyclin D1, resulting in carcinogenesis (Aihara et al., 2016) . However, Bub1 was identified as a mitotic kinase in yeast and was found to phosphorylate H2A S121 (equivalent to T120 in mammals) (Kawashima et al., 2010) . This phosphorylation is recognized by Shugoshin protein and is important for chromosome segregation. In this study, we showed that human BUB1 phosphorylates H2A in nucleosomal arrays assembled in vitro. In addition, human BUB1 was localized to the centromeric DXZ1 and pericentromeric γ-ALR junction sequences, and their H2A T120 phosphorylation was found to increase during mitosis. Thus, it is suggested that VRK1 and BUB1 are nonredundant in H2A phosphorylation activity. VRK1 contributes H2A T120 phosphorylation around promoter regions or inappropriate bulk H2A T120 hyperphosphorylation in certain cancer cell lines. However, BUB1 contributes to mitotic H2A T120 phosphorylation, both centromeric and pericentromeric, as summarized in Figure 7 .
In this study, we showed that repression of H2A T120 phosphorylation by depletion of BUB1 induces chromosome missegregation in human cells. The phosphorylation of H2A T120 by Bub1 has been shown to localize Shugoshin protein to prevent chromosomal instability (Boyarchuk, Salic, Dasso, & Arnaoutov, 2007; Kawashima et al., 2010; Yamagishi, Honda, Tanno, & Watanabe, 2010) . However, Bub1 over-expression has been shown to induce aneuploidy and tumor formation through hyperactivation of Aurora B kinase . Chromosome missegregation induced by over-expression of Bub1 was repressed by the inhibition of Aurora B kinase. Thus, this enzyme has been suggested as playing a key role in over-expressed Bub1-mediated chromosomal instability. Taken together, these findings suggest a dual system of chromosomal dynamics regulated by Bub1, one by activation of Aurora B kinase and the other by H2A phosphorylation. To help prevent carcinogenesis in human Forty-eight hours after siControl, siBUB1-1, or siBUB1-2 treatment or 20 hr after demecolcine treatment, HeLa cells were fixed. More than 100 cells were counted and divided into categories for the large nucleus, multinucleation, inappropriate metaphase, normal metaphase, and S phase plus interphase (G1/S) using nine independent immunostainings. M phase did not include abnormal-featured M phase, and G1/S phase did not include large nuclei or multinucleated cells. (b, c) Mutant histones H2A T120A, T120D, and T120E were stably over-expressed in HeLa cells. Fortyeight hours after BUB1 knockdown, the nuclei were observed. For each condition, more than 800 cells were counted and divided into categories for the large nucleus, multinucleation, inappropriate metaphase, normal metaphase, and S phase plus interphase (G1/S) using nine independent immunostainings. The percentages of abnormal nuclei, including large nucleus, multinucleated cells, and inappropriate metaphase, are shown cells, BUB1 may play important roles in the repression of chromosomal instability by its action in multiple systems that regulate chromosome segregation.
| EXPERIMENTAL PROCEDURES
| Expression and purification of recombinant hBUB1
FLAG-tagged hBUB1 was produced in E. coli strain Rosetta (DE3) with the pLysS vector (Invitrogen). E. coli lysate in which FLAG-tagged hBUB1 was expressed was immunopurified with FLAG M2 agarose (Sigma-Aldrich). After extensive washing of the agarose, FLAG-tagged hBUB1 was eluted with FLAG peptide (Sigma-Aldrich) and dialyzed against 50 mM KCl in HEG buffer (10 mM HEPES, pH 7.6, 0.5 mM EDTA, and 10% glycerol).
| Generation of antibodies
Rabbits were immunized with Drosophila core histones or recombinant full-length BUB1, and the sera were collected and tested for specificity, as shown in Supporting Information Figures S1-S3.
| Reconstitution of nucleosomes by salt dialysis
Chromatin was assembled using salt dialysis as described previously (Aihara et al., 2016) . In brief, it was reconstituted by mixing 100 μg of supercoiled pGIE0 plasmid DNA and 100 μg of purified Drosophila core histones or HeLa cell core histones in 1 M NaCl and subsequent salt dialysis with a final buffer containing 20 mM Tris-HCl (pH 7.2), 0.2 mM EDTA, and 50 mM NaCl. The appropriately reconstituted chromatin was enriched by a 15%-40% (w/v) glycerol gradient sedimentation (375,000g for 6 hr at 4°C; Beckman SW60 rotor). The gradient fractions that contained the fastest migrating chromatin (which included the fully reconstituted nucleosomes) were pooled, dialyzed against HEG buffer containing 50 mM KCl, and stored at 4°C.
| In vitro phosphorylation
To detect histone H2A phosphorylation, 10 ng of purified recombinant hBUB1 or 0.8 μl of 10 ng/μl purified native dNHK was incubated with 40 ng of chromatin as substrate in 1 nM ATP, 10 mM HEPES (pH 7.6), 50 mM KCl, and 5 mM MgCl 2 for 2 hr at 37°C. Reaction mixtures were separated by 13% SDS-PAGE and subjected to western blotting and dot blotting using rabbit anti-hH2A pT120 antibodies after blocking the membrane with 3% BSA and subsequent detection with chemiluminescence (Pierce).
| Cell culture and siRNA transfection
HeLa cells were cultured in a humidified chamber (37°C, 5% CO 2 in air) with Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 μg/ml gentamicin and 10% fetal calf serum (Life Technologies). One day before transfection, the cells were seeded typically at a density of 0. GGGCUUGGGGAGUCAAUAAGA) or nontargeting siRNA (GUACCGCACGUCAUUCGUAUC) was carried out using Lipofectamine ® RNAiMAX transfection reagent (Invitrogen) and OptiMEM serum-free medium (Invitrogen). To determine cell growth, cells were counted in triplicate at 72 hr and 96 hr after siRNA transfection. Cells were fixed for immunohistochemistry or collected by trypsinization for FACS analysis at 48 hr after siRNA transfection.
| FACS analysis
HeLa cells were treated with 1 μM staurosporine as an apoptosis positive control, as indicated. For knockdown experiments, HeLa cells were treated with an siBUB1 oligo or control oligo. Twenty-two hours after staurosporine treatment or 48 hr after siRNA treatment, the cells were subjected to a TUNEL assay according to the manufacturer's instructions (DeadEnd Fluorometric TUNEL System, Promega). Apoptosisfragmented DNA was labeled with fluorescein-12-dUTP. In addition, HeLa cell DNA was stained with propidium iodide and analyzed using a FACSCanto™ II flow cytometer.
| Immunofluorescence studies
Forty-eight hours after siRNA transfection, the cells were fixed in −30°C methanol for 4 min. HeLa cells were incubated with anti-α-tubulin mouse monoclonal antibodies (1:400, Sigma-Aldrich, Cat. No. T5168) and purified rabbit polyclonal anti-BUB1 antibodies (1:800 IgG antibodies (1:250, Life Technologies, Cat. No. A21050). DNA was stained with Hoechst 33342 dye (1:2,000), and images were collected using a deconvolution microscope (Olympus FV1000D-IX81).
| ChIP-qPCR
For analysis of cell cycle-dependent H2A T120 phosphorylation and hBUB1 localization in HeLa cells, M phase cells were collected after colcemid treatment, and S phase cells were collected after hydroxyurea treatment. ChIP-qPCR was carried out as previously described. Cultured cells were collected, fixed for 10 min in 1% formaldehyde, neutralized with glycine (0.124 M), and incubated for 10 min at 4°C in lysis buffer. The nuclei were pelleted, resuspended in lysis buffer, and sonicated 15 times for 10 s at 20% amplitude using a Digital Sonifier (Branson). The lysates were then centrifuged to remove debris. Supernatants from the lysates were stored at −80°C until use. The supernatants were incubated overnight with anti-hH2A (pT120), anti-hBUB1, and Protein G Sepharose beads (GE Healthcare). The beads were then washed with RIPA buffer, high-salt buffer, and LiCl buffer and twice with TE buffer and incubated with TE buffer containing RNase A for 30 min at 37°C. The beads were then incubated with elution buffer for 12 hr at 65°C to reverse the cross-linking. To dilute the SDS, TE buffer was added to the beads, followed by 8 μl of 10 mg/ml Proteinase K (200 μg/ ml final concentration), and the beads were incubated for 2 hr at 55°C. The lysates were then transferred to a MaXtract High Density Tube (Qiagen), and the DNA was purified by phenol-chloroform extraction followed by ethanol precipitation, according to the manufacturer's instructions. Primers for ChIP-qPCR were previously described.
| In vivo antitumor assay
HeLa cells (4 × 10 6 ) and Matrigel matrix (Becton Dickinson) were mixed in equal volumes and injected into the flanks of 8-week-old BALB/cA Jcl-nu/nu mice (n = 9 in experiments with both siBUB1 and control). The tumors were measured in two dimensions using micrometer calipers, and the tumor volume was estimated according to the formula: 0.5 × ((shortest diameter) 2 × (longest diameter)). When the average tumor volume exceeded 150 mm 3 , siBUB1-2 or siControl duplexes (5 mg) together with 4 ml of Gene Silencer reagent (Gene Therapy System, San Diego, CA, USA) dissolved in 50 ml DMEM were directly injected into the tumors twice weekly. The results are expressed as mean ± SEM. Student's t test was used for statistical analysis, and a probability value <0.05 was regarded as statistically significant. All animal experiments were approved by the Institutional Animal Care and Use Committee.
